SMAD7 antibody
-
- Target See all SMAD7 Antibodies
- SMAD7 (SMAD, Mothers Against DPP Homolog 7 (SMAD7))
-
Reactivity
- Human, Mouse, Rat
-
Host
- Rabbit
-
Clonality
- Polyclonal
-
Conjugate
- This SMAD7 antibody is un-conjugated
-
Application
- ELISA, Immunohistochemistry (IHC)
- Purification
- Affinity purification
- Immunogen
- Synthetic peptide of human SMAD7
- Isotype
- IgG
- Top Product
- Discover our top product SMAD7 Primary Antibody
-
-
- Application Notes
- IHC 1:50-1:200
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 0.4 mg/mL
- Buffer
- PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4
- Preservative
- Sodium azide
- Handling Advice
- Avoid freeze / thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- SMAD7 (SMAD, Mothers Against DPP Homolog 7 (SMAD7))
- Alternative Name
- SMAD7 (SMAD7 Products)
- Synonyms
- CRCS3 antibody, MADH7 antibody, MADH8 antibody, Smad7a antibody, Madh7 antibody, Smad10 antibody, madh7 antibody, xsmad7 antibody, wu:fj60c10 antibody, SMAD family member 7 antibody, SMAD family member 7 L homeolog antibody, SMAD7 antibody, Smad7 antibody, smad7.L antibody, smad7 antibody
- Background
- The protein encoded by this gene is a nuclear protein that binds the E3 ubiquitin ligase SMURF2. Upon binding, this complex translocates to the cytoplasm, where it interacts with TGF-beta receptor type-1 (TGFBR1), leading to the degradation of both the encoded protein and TGFBR1. Expression of this gene is induced by TGFBR1. Variations in this gene are a cause of susceptibility to colorectal cancer type 3 (CRCS3). Several transcript variants encoding different isoforms have been found for this gene.
- NCBI Accession
- NP_005895
- Pathways
- Interferon-gamma Pathway, Cell-Cell Junction Organization
-